Long-term results of allogenic penetrating limbo-keratoplasty: 20 years of experience

被引:27
作者
Lang, S. J. [1 ,3 ]
Boehringer, D. [1 ]
Geerling, G. [2 ]
Reinhard, T. [1 ]
机构
[1] Univ Freiburg, Fac Med, Ctr Eye, Med Ctr, Freiburg, Germany
[2] Univ Dusseldorf, Dept Ophthalmol, Dusseldorf, Germany
[3] Univ Freiburg, Fac Med, Med Ctr, Ctr Eye, Killianstr 5, D-79106 Freiburg, Germany
关键词
STEM-CELL DEFICIENCY; BOSTON TYPE-1 KERATOPROSTHESIS; CORNEAL EPITHELIUM; AMNIOTIC MEMBRANE; CYCLOSPORINE-A; OUTCOMES; TRANSPLANTATION; COMPLICATIONS; INSUFFICIENCY; IMPLANTATION;
D O I
10.1038/eye.2016.217
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim The objective of the study was to evaluate the long-term results of allogenic penetrating limbo-keratoplasy. This method allows simultaneous transplantation of a corneal graft and limbal stem cells of the donor by means of eccentric trephination of the donor button. Method The data of 192 consecutive cases of allogenic penetrating limbo-keratoplasty from 1995 to 2015 were reviewed. These had been performed exclusively in eyes with complete failure of the limbal stem cells, in combination with deep corneal scarring. Indications were predominantly eye burns, inflammatory conditions, and congenital aniridia. Graft survival and rejection rates were assessed using Kaplan-Meier analysis. Results Follow-up averaged 2.1 +/- 2.2 years. Median graft survival was 3.4 years in eye burns, 3.9 years in inflammatory disease, and 3.2 years in congenital aniridia. Median survival was 3.9 years in the heterogenous group of other indications. Conclusion Allogenic limbo-keratoplasty is a suitable option used to treat patients with bilateral complete failure of the limbal stem cells and deep opacification of the central cornea. The main reasons for graft failure are the loss of graft-limbal stem cell functioning and endothelial graft rejection.
引用
收藏
页码:372 / 378
页数:7
相关论文
共 30 条
[1]   Predictors of Visual Outcomes Following Boston Type 1 Keratoprosthesis Implantation [J].
Ahmad, Sumayya ;
Akpek, Esen K. ;
Gehlbach, Peter L. ;
Dunlap, Karen ;
Ramulu, Pradeep Y. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 159 (04) :739-747
[2]   Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty:: A retrospective study [J].
Birnbaum, F ;
Böhringer, D ;
Sokolovska, Y ;
Sundmacher, R ;
Reinhard, T .
TRANSPLANTATION, 2005, 79 (08) :964-968
[3]   Long-Term Graft Survival in Penetrating Keratoplasty: The Biexponential Model of Chronic Endothelial Cell Loss Revisited [J].
Boehringer, Daniel ;
Bohringer, Stefan ;
Poxleitner, Katharina ;
Birnbaum, Florian ;
Schwartzkopff, Johannes ;
Maier, Philip ;
Sundmacher, Rainer ;
Reinhard, Thomas .
CORNEA, 2010, 29 (10) :1113-1117
[4]   Predicting time on the waiting list for HLA matched corneal grafts [J].
Böhringer, D ;
Reinhard, T ;
Böhringer, S ;
Enczmann, J ;
Godehard, E ;
Sundmacher, R .
TISSUE ANTIGENS, 2002, 59 (05) :407-411
[5]   Quality of life associated with visual loss - A time tradeoff utility analysis comparison with medical health states [J].
Brown, MM ;
Brown, GC ;
Sharma, S ;
Busbee, B .
OPHTHALMOLOGY, 2003, 110 (06) :1076-1081
[6]  
CHEN JJY, 1991, INVEST OPHTH VIS SCI, V32, P2219
[7]  
Dua H S, 2000, Indian J Ophthalmol, V48, P83
[8]  
Eberwein P, 2011, OPHTHALMOLOGE, V108, P840, DOI 10.1007/s00347-011-2332-y
[9]   Allogenic Limbo-keratoplasty with Conjunctivoplasty, Mitomycin C, and Amniotic Membrane for Bilateral Limbal Stem Cell Deficiency [J].
Eberwein, Philipp ;
Boehringer, Daniel ;
Schwartzkopff, Johannes ;
Birnbaum, Florian ;
Reinhard, Thomas .
OPHTHALMOLOGY, 2012, 119 (05) :930-937
[10]   Longer-Term Vision Outcomes and Complications with the Boston Type 1 Keratoprosthesis at the University of California, Davis [J].
Greiner, Mark A. ;
Li, Jennifer Y. ;
Mannis, Mark J. .
OPHTHALMOLOGY, 2011, 118 (08) :1543-1550